Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

 This program is not active.
Webinar

International: After the federal election – where is Germany heading in cannabis policy?


Average Rating:
   4
Categories:
Federal Law |  Regulation law
Faculty:
Kai-Friedrich Niermann |  Jakob Sons |  Daniel Haymann, MBA
Duration:
1 Hour
Format:
Audio and Video
SKU:
INCBA102821INTLWEB
License:
Product Setting: Expires 6 month(s) after program date.

Dates


Description

With the upcoming federal elections on 26 September 2021, Germany is facing a possible turning point in cannabis policy. The last reform of the regulations on industrial hemp was 25 years ago, and medicinal cannabis was only legalised in 2017. All leading parties agree that a liberalization of recreational cannabis use must also take place. The webinar will discuss the results of the federal election, how likely full legalization will be and how it will affect the medical cannabis market.

Credits


General

This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)


For current accreditation status, please select your jurisdiction below.



Handouts

Faculty

Kai-Friedrich Niermann's Profile

Kai-Friedrich Niermann Related Seminars and Products

Lawyer

KFN+


Kai is characterized by his outstanding expertise and diverse practice in the cannabis industry. With a broad range of expertise in cannabis and business law, he provides comprehensive legal support to companies and individuals.

From contract drafting and company formation to day-to-day legal support, he assists cannabis companies with customized solutions in all legal matters, including white collar criminal law where necessary.

Kai is also the author of the blog canna-biz.legal, where he positions himself as an expert in the thriving cannabis business. Canna-biz.legal not only provides insights into the legal status of cannabis in Germany and Europe today, but also current developments and offers resources for businesses and interested parties.

His work spans all aspects of the cannabis industry, from advising companies on cultivation licenses and production regulations to assisting with regulatory issues in product development. His deep understanding of the complex legal framework in this sector makes him a sought-after contact.

Kai and his law firm KFN+ advise large CBD and medical cannabis companies, as well as companies and associations interested in the emerging recreational cannabis market. He is also advisor to the European Industrial Hemp Association (EIHA), which has submitted a joint application to the EU Commission for authorization as a novel food for various CBD products.

With an international perspective, Kai operates not only nationally, but also across borders. His network in the industry enables him to support companies in their global activities and adapt to the challenges of an ever-changing legal landscape.

Kai regularly speaks at international cannabis conferences on topics related to the German and European legal framework for cannabis, and publishes articles at Krautinvest, BusinessCann and in law journals.

Born in Löhne/Westf. in 1972, studied law at the Universities of Marburg, Adelaide (Australia), Cologne, legal assistant at the press center of the German Bundestag (2000-2002), worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Berlin Office for the Protection of the Constitution and the Hong Kong Consulate General.

Areas of Law:

  • Legal Cannabis Consulting
  • Regulatory approvals for medical cannabis and CBD
  • Business law (company, commercial and contract law) 
  • Law of torts
  • Criminal business law

 


Jakob Sons's Profile

Jakob Sons Related Seminars and Products

Co-Founder and General Counsel

Cansativa


Jakob Sons is co-founder, Managing Director and General Counsel of Cansativa in Germany. Jakob studied law at the Universities of Heidelberg and Würzburg and started his professional carrier as a corporate and commercial litigation lawyer with international law firms based in Frankfurt am Main. He is a PhD candidate at the University of Marburg focusing on Pharmaceutical Law and the national and international regulation of Cannabis as a pharmaceutical product. Jakob is leading the legal and regulatory team at Cansativa and, inter alia, managed the GMP/GDP-certification of two German sites of the company and prepared the first importation of product samples from LatAm and Australia.


Daniel Haymann, MBA's Profile

Daniel Haymann, MBA Related Seminars and Products

Legal Counsel

MME Legal | Tax | Compliance


Daniel Haymann specializes in corporate and commercial law. Based on his extensive business experience, he has a good feel for new markets and understands the requirements of go-to-market and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.

He advises investors, start-ups and vertically integrated companies along the value chain, including on regulatory issues relating to THC, CBD and other cannabinoids and psychoactive substances, GMP and GDP standards, food and cosmetics regulations and approval procedures before Swissmedic, the Swiss remedy institute.

Daniel is co-founder and co-chair of the European branch of the International Cannabis Bar Association (INCBA Europe). As a Swiss-Israeli dual citizen, he also focuses on serving clients with connections to Israel and strengthening the relevant business relationships.

Prior to his career as a lawyer, Daniel spent over 10 years in senior positions as a commodity trader for multinational corporations.


Reviews

5
4
3
2
1

Overall:      5

Total Reviews: 4